Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial (Q35086586)

6 August 2017

Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial (English)

1 reference

6 August 2017

1 reference

7

Janet S Carpenter

1 reference

6 August 2017

6

Hadine Joffe

1 reference

6 August 2017

3

Bette Caan

1 reference

6 August 2017

1

Ellen W Freeman

1 reference

6 August 2017

10

Kristine E Ensrud

1 reference

6 August 2017

4

Barbara Sternfeld

1 reference

6 August 2017

15

Andrea Z LaCroix

1 reference

6 August 2017

2

Katherine A Guthrie

1 reference

6 August 2017

11

Susan D Reed

1 reference

6 August 2017

12

Katherine M Newton

1 reference

6 August 2017

Lee S Cohen

5

1 reference

6 August 2017

Garnet L Anderson

8

1 reference

6 August 2017

Joseph C Larson

9

1 reference

6 August 2017

Sheryl Sherman

13

1 reference

6 August 2017

Mary D Sammel

14

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

The Journal of the American Medical Association

6 August 2017

1 reference

6 August 2017

305

1 reference

6 August 2017

3

1 reference

6 August 2017

267-274

1 reference

Minimum trial duration to reasonably assess long-term efficacy of nonhormonal hot flash therapies

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Use of antidepressants for management of hot flashes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Beyond frequency: who is most bothered by vasomotor symptoms?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Symptoms associated with menopausal transition and reproductive hormones in midlife women

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

A brief measure for assessing generalized anxiety disorder: the GAD-7.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Hormone therapy prescribing patterns in the United States

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

The PHQ-9: validity of a brief depression severity measure

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Role of ethnicity in the expression of features of hot flashes.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Paroxetine versus placebo for women in midlife after hormone therapy discontinuation

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Ethnicity and vasomotor symptoms in postmenopausal women

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Efficacy of citalopram on climacteric symptoms.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Monitoring depression treatment outcomes with the patient health questionnaire-9.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Risk factors for menopausal hot flashes.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3129746

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

27 September 2018

1 reference

12 December 2020

Smoking, body mass, and hot flashes in midlife women

1 reference

12 December 2020

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory

1 reference

12 December 2020

Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation

1 reference

12 December 2020

Identifiers

DOI

10.1001/JAMA.2010.2016

1 reference

6 August 2017

1 reference

6 August 2017

1 reference